Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-05-15
2007-05-15
Saoud, Christine J. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S351000, C435S069100, C435S069500, C435S069700, C514S012200
Reexamination Certificate
active
10268951
ABSTRACT:
The invention relates to human TNF delta and TNF epsilon polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
REFERENCES:
patent: 5487984 (1996-01-01), Allet et al.
patent: 5925548 (1999-07-01), Beutler et al.
patent: 6171787 (2001-01-01), Wiley
patent: 6297022 (2001-10-01), McDonnell et al.
patent: 6297367 (2001-10-01), Tribouley
patent: 6541224 (2003-04-01), Yu et al.
patent: 0 911 633 (1999-04-01), None
patent: 0 919 620 (1999-08-01), None
patent: WO93/16178 (1993-08-01), None
patent: WO97/33902 (1997-09-01), None
patent: WO99/00518 (1999-01-01), None
patent: WO99/11791 (1999-03-01), None
patent: WO99/12965 (1999-03-01), None
patent: WO99/28462 (1999-06-01), None
patent: WO99/33980 (1999-07-01), None
patent: WO99/35170 (1999-07-01), None
patent: WO99/50416 (1999-10-01), None
patent: WO99/54460 (1999-10-01), None
patent: WO99/55858 (1999-11-01), None
patent: WO00/26244 (2000-05-01), None
patent: WO00/32776 (2000-06-01), None
patent: WO00/37640 (2000-06-01), None
patent: WO00/50597 (2000-08-01), None
patent: WO00/55320 (2000-09-01), None
patent: WO00/68378 (2000-11-01), None
patent: WO00/77256 (2000-12-01), None
patent: WO01/24811 (2001-04-01), None
patent: WO01/25256 (2001-04-01), None
patent: WO01/58949 (2001-08-01), None
patent: WO01/60397 (2001-08-01), None
patent: WO01/77291 (2001-10-01), None
patent: WO01/81417 (2001-11-01), None
patent: WO01/87979 (2001-11-01), None
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Wells, Aditivity of Mutational Effects in Proteins, 1990, Biochemistry, vol. 26, No. 37, pp. 8509-8517.
U.S. Appl. No. 09/912,293, Not Published, Rosen et al.
Adams et al., GenBank Accession No. M78230, 1992.
Alignment of SEQ ID No. 1 to Adams et al., GenBank Accession No. M78230 (May 26, 1992).
Cross et al., “Purification of CpG islands using a methylated DNA binding column,” Nature Genetics 6:236-44, 1994.
Gruss and Dower, “Tumor Necrosis Factor Ligand Superfamily: Involvement in the Pathology of Malignant Lymphomas,” Blood 85(12):3378-3404, 1995.
Burns, The Science of Genetics: An Introduction to Heredity, 4th Edition, MacMillan Publishing Co., New York, p. 220, 1980.
George et al., “Current Methods in Sequence Comparison and Analysis,” in Macromolecular Sequencing and Synthesis: Selected Methods and Applications, edited by D. Schlesinger, Alan R. Liss, Inc., New York, pp. 127-149, 1988.
Adams et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence,” Nature 377 (67541 supplement), pp. 3-174, 1995.
MacDonald et al., GenBank Accession No. Z60980, 1995.
Adams et al., GenBank Accession No. AA337828, 1997.
Adams et al., GenBank Accession No. AA360555, 1997.
Adams et al., GenBank Accession No. AA361896, 1997.
Adams et al., GenBank Accession No. AA366583, 1997.
Adams et al., GenBank Accession No. AA357370, 1997.
Hillier et al., GenBank Accession No. W20131, 1996.
Hahne et al., “APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth,” Journal of Experimental Medicine 188(6):1185-1190, 1998.
Kelly et al., “APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death,” Cancer Research 60(4):1021-1027, 2000.
Marsters et al., “Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI,” Current Biology 10(13):785-788, 2000.
Wu et al., “Tumor Necrosis Factor Receptor Superfamily Member TACI is a High Affinity Receptor for TNF Family Members APRIL and BLyS,” Journal of Biological Chemistry in press Manuscript M005224200, published Journal of Biological Chemistry 275(45):35478-35485, 2000.
Rennert et al., “A Soluble Form of B Cell Maturation Antigen, a Receptor for the Tumor Necrosis Factor Family Member APRIL, Inhibits Tumor Cell Growth,” Journal of Experimental Medicine 192(11):12677-12683, 2000.
Ware, “APRIL and BAFF Connect Autoimmunity and Cancer,” Journal of Experimental Medicine 192(11):F35-F37, 2000.
Alignment of SEQ ID No. 2 to Ito et al., PIR51 Accession No. A25451 (1986).
Yu et al., “APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity,” Nature Immunology 1(3):252-256, 2000.
“Sequence Listing Comparison for Sequence database” cited by Examiner with Office Action of Dec. 9, 1998 in related U.S. Appl. No. 08/815,783.
Roth et al., “APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis,” Cell Death and Differentiation 8:403-410, 2001.
Von Bulow et al., “Regulation of the T-Independent Humoral Response by TACI,” Immunity 14:573-582, 2001.
Xu and Lam, “B-Cell Maturation Protein, Which Binds the Tumor Necrosis Factor Family Members BAFF and APRIL, Is Dispensable for Humoral Immune Responses,” Molecular and Cellular Biology 21(12):4067-4074, 2001.
Khare and Hsu, “The role of TALL-1 and APRIL in immune regulation,” TRENDS In Immunology 22(2):61-63, 2001.
Laabi and Strasser, “Lymphocyte Survival—Ignorance is BLys,” Science 289(5481):883, 2000.
Shu et al., “TALL-1 is a novel member of the TNF family that is down-regulated by mitogens,” Journal of Leukocyte Biology 65:680-683, 1999.
Adams et al., “Sequence identification of 2,375 human brain genes,”Nature, 344:632-634 (Feb. 13, 1992).
Gentz Reiner L.
Ni Jian
Yu Guo-Liang
Human Genome Sciences Inc.
Saoud Christine J.
Seharaseyon Jegatheesan
LandOfFree
Human tumor necrosis factor delta polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tumor necrosis factor delta polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tumor necrosis factor delta polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3726424